Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
27.1M
-
Number of holders
-
170
-
Total 13F shares, excl. options
-
26.3M
-
Shares change
-
-871K
-
Total reported value, excl. options
-
$640M
-
Value change
-
-$34.5M
-
Put/Call ratio
-
0.48
-
Number of buys
-
76
-
Number of sells
-
-101
-
Price
-
$24.35
Significant Holders of Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) as of Q2 2024
220 filings reported holding ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock as of Q2 2024.
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) has 170 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.3M shares
of 27.1M outstanding shares and own 96.83% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (4.69M shares), BlackRock Inc. (2.65M shares), ARK Investment Management LLC (1.96M shares), Nikko Asset Management Americas, Inc. (1.56M shares), Sumitomo Mitsui Trust Holdings, Inc. (1.56M shares), STATE STREET CORP (1.52M shares), VANGUARD GROUP INC (1.38M shares), DIMENSIONAL FUND ADVISORS LP (918K shares), MORGAN STANLEY (796K shares), and Woodline Partners LP (754K shares).
This table shows the top 170 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.